Has Mani Daneshmand, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,944 in general payments to Mani Daneshmand, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mani Daneshmand, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mani Daneshmand, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mani Daneshmand, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Atlanta, GANPI 1962676700

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Abbott at 47.9% of the total. Reporting peaked in 2023 at $6,408 and has fallen 52.1% since, to $3,071 in 2025.

$20,944in general payments, 2019–2025

Across 85 payments — averaging $246.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$10K
Abiomed$5K
Fresenius USA Marketing, Inc.$4K
Atricure, Inc.$665
Medtronic$341
Getinge USA Sales, LLC$317
plus $384 from 4 others

$904,530in research payments, 2019–2025

Across 189 payments — averaging $4785.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Transmedics, Inc.$430K
Xvivo Perfusion Inc.$260K
Abbott$138K
Briohealth Solutions, Inc.$58K
Atricure, Inc.$12K
United Therapeutics Corporation$5K
plus $2K from 2 others

What the payments were for

Consulting fees$3,92919%
Speaking & faculty fees$2,75013%
Travel & lodging$10,66651%
Food & beverage$3,35416%
Education$2451%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	28	$10,027
Abiomed	24	$4,951
Fresenius USA Marketing, Inc.	8	$4,260
Atricure, Inc.	11	$665
Medtronic(2 entities)	4	$341
Getinge USA Sales, LLC	5	$317
Paragonix Technologies, Inc.	1	$197
Edwards Lifesciences	2	$107
Johnson & Johnson	1	$56
Briohealth Solutions, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THORATEC HEARTMATE 3 LVAS IMPLANT KIT$8,625
Impella$2,178
HeartMate 3 Left Ventricular Assist Device$751
SherpaPak$197
LIVERguard$197
LUNGguard$197
BaroGuard$197
PancreasPak$197
ADVISOR$165
HeartWare HVAD$159
HeartMate Touch$157
CARDIOMEMS$131
EPI-EASE EPICARDIAL ACCESS SYSTEM$120
ATRICURE ATRICLIP LAA EXCLUSION$111
CARDIOHELP$105

How this compares

$20,944 in reported general payments places this provider in the 75th percentile of 144 thoracic surgery (cardiothoracic vascular surgery) providers in Georgia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Georgia →

Medicare billing

Part B allowed, 2024

$85,577

Medicare patients

Services billed

103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	25	$9,809
Enoxaparin Sodium	18	$1,700
Mycophenolate Mofetil	15	$910
Pantoprazole Sodium	24	$178
Metoprolol Tartrate	20	$101
Atorvastatin Calcium	21	$90
Pravastatin Sodium	14	$58
Alendronate Sodium	14	$53
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	15	$15

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Atlanta

Manu SanchetiAtlanta$805K
John PuskasAtlanta$332K
Douglas MurphyAtlanta$254K
Ezequiel MolinaAtlanta$215K
Gaetano PaoneAtlanta$134K
Michael HalkosAtlanta$102K
Allan PickensAtlanta$87K
Bradley LeshnowerAtlanta$63K
Kimberly HolstAtlanta$52K
William KeelingAtlanta$49K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →